Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats

European Journal of Pharmacology

Volumn 584, Issue 2-3, 2008, Pages 368-375

  Chen, Shuang Xiu ^a,b   Song, Tao ^a   Zhou, Shou Hong ^a   Liu, Yu Hui ^a   Wu, Shu Jing ^a   Liu, Li Ying ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Yueyang Occupation and Technology Academy   (China)

Author keywords

Advanced oxidation protein products; Captopril; Enalapril; Oxidative stress; Vascular endothelial function

Indexed keywords

BOVINE SERUM ALBUMIN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRITE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; KIDNEY FUNCTION; MALE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; THORACIC AORTA; UREA NITROGEN BLOOD LEVEL; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD UREA NITROGEN; CAPTOPRIL; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENALAPRIL; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; GLUTATHIONE PEROXIDASE; GLYCOSYLATION END PRODUCTS, ADVANCED; INJECTIONS, INTRAVENOUS; KIDNEY; MALE; MALONDIALDEHYDE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, SPRAGUE-DAWLEY; SERUM ALBUMIN, BOVINE; SUPEROXIDE DISMUTASE; VASODILATION; VASODILATOR AGENTS;

EID: 41349101933     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.02.020     Document Type: Article

References (29)

1. Aberg G., and Ferrer P. Effects of captopril on atherosclerosis in cynomolgus monkeys. J. Cardiovasc Pharmacol. 15 (1990) S65-S72
2. Alderman C.J., Shah S., Foreman J.C., Chain B.M., and Katz D.R. The role of advanced oxidation protein products in regulation of dendritic cell function. Free Radic. Biol. Med. 32 (2002) 377-385
3. Anning P.B., Grocott-Mason R.M., and Lewis M.J. Effects of sulphydryl- and non-sulphydryl-containing ACE inhibitors on left ventricular relaxation in the isolated guinea pig heart. Endothelium 5 (1997) 265-275
4. Buonocore G., Perrone S., Longini M., Vezzosi P., Marzocchi B., Paffetti P., and Bracci. Oxidative stress in preterm neonates at birth and on the seventh day of life. Pediatr. Res. 52 (2002) 46-49
5. Capeille're-Blandin C., Vale'rie G., Descamps-Latsch B., and Witko-Sarsat V. Biochemical and spectrophotometric significance of advanced oxidized protein products. Biochim. Biophys. Acta 1689 (2004) 91-102
6. Chen S., Liu L., Sun X., Liu Y., and Song T. Captopril restores endothelium-dependent relaxation induced by advanced oxidation protein products in rat aorta. J. Cardiovasc. Pharmacol. 46 6 (2005) 803-809
7. de Nigris F., D'Armiento F.P., Somma P., Casini A., Andreini I., Sarlo F., Mansueto G., De Rosa G., Bonaduce D., Condorelli M., and Napoli C. Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice. Int. J. Cardiol. 81 (2001) 107-115
8. Descamps-Latscha B., Witko-Sarsat V., Nguyen-Khoa T., Nguyen A.T., Gausson V., Mothu N., London G.M., and Jungers P. Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients. Am. J. Kidney Dis. 45 1 (2005) 39-47
9. Drueke T., Witko-Sarsat V., Massy Z., Descamps-Latscha B., Guerin A.P., Marchais S.J., Gausson V., and London G.M. Iron therapy, advanced oxidation protein products, and carotid artery intimamedia thickness in end-stage renal disease. Circulation 106 (2002) 2212-2217
10. Flohe L., and Gunzler W.A. Asseys of glutathione peroxidase. Methods Enzymol. 105 (1984) 114-121
11. Fu S., Wang H., Davies M., and Dean R. Reactions of hypochlorous acid with tyrosine and peptidyl-tyrosyl residues give dichlorinated and aldehydic products in addition to 3-chlorotyrosine. J. Biol. Chem. 275 15 (2000) 10851-10858
12. Fu Y.F., Xiang Y., and Fu S.H. Captopril restores endothelium-dependent relaxation of rat aortic rings after exposure to homocysteine. J. Cardiovasc. Pharmacol. 42 2 (2003) 566-572
13. Grafe M., Bossaller C., Graf K., Auch-Schwelk W., Baumgarten C.R., Hildebrandt A., and Fleck E. Effect of angiotensin-converting enzyme inhibition on bradykinin metabolism by vascular endothelial cells. Am. J. Physiol. 264 (1993) H1493-H1497
14. Himmelfarb J., and McMonagle E. Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int. 60 1 (2001) 358-363
15. Hernandez A., Barberi L., Ballerio R., Testini A., Ferioli R., Bolla M., Natali M., Folco G., and Catapano A.L. Delapril slows the progression of atherosclerosis and maintains endothelial function in cholesterol-fed rabbits. Atherosclerosis 137 (1998) 71-76
16. Kalousova M., Krha J., and Zima T. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol. Res. 51 (2002) 597-604
17. Kaneda H., Taguchi J., Ogasawara K., Aizawa T., and Ohno M. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis 162 (2002) 221-225
18. Liao D.F., and Chen X. Prostacyclin-mediated protection by angiotensin converting enzyme inhibitors against injury of aortic endothelium by free radicals. Cardioscience 3 (1992) 79-84
19. Liu Y.H., Liu L.Y., Wu J.X., Chen S.X., and Sun X.Y. Comparison of captopril and enalapril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE inhibitors in high dieted methionine mice. J. Cardiovasc. Pharmacol. 47 1 (2006) 82-88
20. Luo H.L., Zang W.J., Lu J., Yu X.J., Lin Y.X., and Cao Y.X. The protective effect of captopril on nicotine-induced endothelial dysfunction in rat. Basic. Clin. Pharmacol. Toxicol. 99 3 (2006) 237-245
21. Morena M., Cristol J.P., Bosc J.Y., Tetta C., Forret G., Leger C.L., Delcourt C., Papoz L., Descomps B., and Canaud B. Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients. Nephrol. Dial. Transplant. 17 3 (2002) 422-427
22. Napoli C., Sica V., de Nigris F., Pignalosa O., Condorelli M., Ignarro L.J., and Liguori A. Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension. Am. Heart J. 148 (2004) e5
23. Nenle T., Deppisch R., Beck W., Hergesell O., Hansch G.M., and Ritz E. Advanced glycated end-products during haemodialysis treatment: discrepent results with different methodologies reflecting the heterogeneity of AGE compounds. Nepheol. Dial. Transplant. 14 (1999) 1968-1975
24. Scribner A.W., Loscalzo J., and Napoli C. The effect of angiotensin-converting enzyme inhibition on endothelial function and oxidant stress. Eur. J. Pharmacol. 15,482 1-3 (2003) 95-99
25. Witko-Sarsat V., Friedlander M., Capeille're-Blandin C., Nguyen-Khoa T., Nguyen A.T., Zingraff J., Jungers P., and Descamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 49 (1996) 1304-1313
26. Witko-Sarsat V., Friedlander M., Nguyen-Khoa T., Capeillere-Blandin C., Nguyen A.T., Canteloup S., Dayer J.M., Jungers P., Drueke T., and Descamps-Latscha B. Advanced oxidation protein products as a novel inflammation and monocyte activation in chronic renal failure. J. Immunol. 161 5 (1998) 2524-2532
27. Wu C.C., Chen J.S., Wu W.M., Liao T.N., Chu P., Lin S.H., Chuang C.H., and Lin Y.F. Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes. Nephrol. Dial. Transplant. 20 6 (2005) 1134-1139
28. Yuan F., Liu S.X., and Tian J.W. Advanced oxidation protein products induce reactive oxygen species production in endothelial cells. J. First. Mil. Med. Univ. 24 2 (2004) 1350-1352
29. Zhang Z.H., Liu S.X., Hou F.F., Tian J.W., Wang L., Liu Z.Q., and Chen Y. Advanced oxidation protein products-induced tumor necrosis factor alpha secretion in monocytes via reactive oxygen species generation. Di Yi JunYi DaXue XueBao. 25 5 (2005) 493-497